CERO Therapeutics entered into a definitive stock purchase agreement to sell its subsidiary CERO Therapeutics, Inc. to SRX Global for shares of SRX common stock and the forgiveness of a secured promissory note.
CERO Therapeutics entered into a definitive stock purchase agreement to sell its subsidiary CERO Therapeutics, Inc. to SRX Global for shares of SRX common stock and the forgiveness of a secured promissory note.